Veranova's Devens Site Clears FDA Inspection with Zero Observations
Veranova's Devens site has successfully completed a routine current Good Manufacturing Practice (cGMP) surveillance inspection by the Food and Drug Administration (FDA).
Veranova | 14/08/2025 | By Dineshwori | 104
Veranova Names Thomas Rohrer as Vice President of Bioconjugation
Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, has appointed Thomas Rohrer as Vice President of Bioconjugation.
Veranova | 29/07/2025 | By Dineshwori
Veranova finishes mid-scale API expansion at Edinburgh facility
The multi-purpose asset, able to handle highly active APIs and intermediates, is positioned to enable growth in the generic opioid analgesic and anti-addiction markets
Veranova | 28/02/2023 | By Sudeep Soparkar | 923
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy